biomedicina slovenica


"Phospholipid antibodies" : 169

  1. Ogrič Manca; Švec Tinka; Žigon Polona; Sodin-Šemrl Snežna; Rotar Žiga; Čučnik Saša
    Autoantibodies in individuals with SARS-COV-2 infection and/or after vaccination with BNT162B2
    2022
  2. Štok Ula; Štucin Neža; Blokar Elizabeta; Ambrožič Aleš; Sodin-Šemrl Snežna; Čučnik Saša; Žigon Polona
    Antiphospholipid antibody syndrome-associated increased surface expression of VLA4 integrin on human monocytes
    2022
  3. Štok Ula; Holcar Marija; Lenassi Metka; Sodin-Šemrl Snežna; Čučnik Saša; Žigon Polona
    Increased levels of small extracellular vesicles released upon stimulation of endothelialcells with antiphospholipid antibodies
    2022
  4. Štok Ula; Štucin Neža; Čučnik Saša; Sodin-Šemrl Snežna; Žigon Polona
    Increased expression of CD49D marker on monocytes in response to stimulation by antiphospholipid antibodies
    2022
  5. Štok Ula; Čučnik Saša; Sodin-Šemrl Snežna; Žigon Polona
    Extracellular vesicles
    2022
  6. Žigon Polona
    Antiphospholipid antibodies - a laboratory criterion for the antiphospholipid syndrome, but also bystanders in infections, cancer, and other conditions
    2022
  7. Žigon Polona
    Antiphospholipid syndrome
    2022
  8. Štok Ula; Blokar Elizabeta; Lenassi Metka; Holcar Marija; Perdan-Pirkmajer Katja; Ambrožič Aleš; Erman Andreja; Resnik Nataša; Sodin-Šemrl Snežna; Čučnik Saša; Žigon Polona
    Phenotype of small plasma extracellular vesicles from antiphospholipid syndrome patients
    2021
  9. Perdan-Pirkmajer Katja; Žigon Polona; Boc Anja; Podovšovnik Eva; Čučnik Saša; Mavri Alenka; Rotar Žiga; Ambrožič Aleš
    The predictive value of the aCL and anti-[beta]2GPI at the time of acute deep vein thrombosis - a two-year prospective study
    2021
  10. Štok Ula; Čučnik Saša; Sodin-Šemrl Snežna; Žigon Polona
    Extracellular vesicles and antiphospholipid syndrome
    2021
  11. Abisror Noemie; Nguyen Yann; Marozio Luca; Esteve Valverde Enrique; Udry Sebastian; Pleguezuelo Daniel Enrique; Billoir Paul; Mayer-Pickel Karoline; Urbanski Geoffrey; Žigon Polona
    Obstetrical outcome and treatments in seronegative primary APS
    2020
  12. Žigon Polona
    Do antiphospholipid antibodies enhance thromboembolic risk in patients with cancer?
    2020
  13. Štok Ula; Blokar Elizabeta; Lenassi Metka; Holcar Marija; Frank Bertoncelj Mojca; Erman Andreja; Resnik Nataša; Sodin-Šemrl Snežna; Čučnik Saša; Perdan-Pirkmajer Katja; Ambrožič Aleš; Žigon Polona
    Characterization of plasma-derived small extracellular vesicles indicates ongoing endothelial and platelet activation in patients with thrombotic antiphospholipid syndrome
    2020
  14. Žigon Polona; Podovšovnik Anuška; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Gašperšič Nataša; Rotar Žiga; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Non-criteria antiphospholipid antibodies in obstetric antiphospholipid syndrome
    2019
  15. Gašperšič Nataša; Zaletel Marjan; Kobal Jan; Žigon Polona; Čučnik Saša; Sodin-Šemrl Snežna; Tomšič Matija; Ambrožič Aleš
    Stroke and antiphospholipid syndrome-antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event
    2019
  16. Perdan-Pirkmajer Katja; Boc Anja; Čučnik Saša; Mavri Alenka; Žigon Polona; Podovšovnik Eva; Štalc Monika; Vene Nina; Ambrožič Aleš
    Predictive value of antiphospholipid antibodies in the acute phase of deep vein thrombosis
    2018
  17. Žigon Polona; Podovšovnik Anuška; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Gašperšič Nataša; Rotar Žiga; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome
    2018
  18. Hočevar Alojzija; Rotar Žiga; Žigon Polona; Čučnik Saša; Ostrovršnik Jaka; Tomšič Matija
    The incidence rate and the early management of rheumatoid arthritis in Slovenia
    2018
  19. Žigon Polona
    Antiphosphospholipid antibodies are associated to adverse pregnancy outcome
    2017
  20. Perdan-Pirkmajer Katja; Boc Anja; Čučnik Saša; Mavri Alenka; Žigon Polona; Podovšovnik Eva; Štalc Monika; Vene Nina; Ambrožič Aleš
    Predictive value of antiphospholipid antibodies in the acute phase of deep vein thrombosis
    2018
  21. Kuret Tadeja; Lakota Katja; Hočevar Alojzija; Burja Blaž; Čučnik Saša; Sodin-Šemrl Snežna
    Evaluating the utility of autoantibodies for disease activity and relapse in giant cell arteritis
    2018
  22. Toplak Nataša; Avčin Tadej
    Paediatric antiphospholipid syndrome
    2016
  23. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    Anti-phospholipid antibodies are associated to adverse pregnancy outcome
    2016
  24. Amengual Olga; Forastiero R.; Sugiura-Ogasawara M.; Otomo K.; Oku Kenji; Favas C.; Delgado Alves J.; Žigon Polona; Ambrožič Aleš; Tomšič Matija
    Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome
    2017
  25. Hočevar Alojzija; Ostrovršnik Jaka; Žigon Polona; Čučnik Saša; Rotar Žiga; Tomšič Matija
    Antiphospholipid antibodies in adult IGA vasculitis
    2017
  26. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    Antiphospholipid antibodies in association to adverse pregnancy outcome
    2016
  27. Žigon Polona; Podovšovnik Anuška; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Gašperšič Nataša; Rotar Žiga; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Association of Conventional Risk Factors and Antiphospholipid Antibodies to thrombosis in patients with autoimmune diseases
    2016
  28. Bizjak Mojca; Bruck Or; Kadunc Darja; Praprotnik Sonja; Shoenfeld Yehuda
    Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine
    2016
  29. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    IGA antiphospholipid antibodies present a thrombotic risk in patients with systemic autoimmune diseases
    2016
  30. Mekinian Arsene; Ambrožič Aleš; Avčin Tadej
    Mothers' antiphospholipid antibodies during pregnancy and the relation to offspring outcome
    2014
  31. Žigon Polona; Božič Mojca; Frank Mojca; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Božič Borut; Sodin-Šemrl Snežna; Kveder Tanja; Čučnik Saša
    Laboratory methodology important in the diagnosis and prognosis of antiphospholipid syndrome
    2015
  32. Gašperšič Nataša; Zaletel Marjan; Kobal Jan; Žigon Polona; Čučnik Saša; Sodin-Šemrl Snežna; Tomšič Matija; Ambrožič Aleš
    Antiphospholipid antibodies in patients with cerebrovascular events
    2015
  33. Žigon Polona; Ambrožič Aleš; Božič Borut; Čučnik Saša
    Protitelesa proti protrombinu
    [Antiprothrombin antibodies]
    2015
  34. Aguiar Cassyanne L.; Soybilgic Arzu; Avčin Tadej; Myones Barry L.
    Pediatric antiphospholipid syndrome
    2015
  35. Mekinian Arsene; Avčin Tadej; Ambrožič Aleš; Tomšič Matija; Novak-Antolič Živa
    European registry of babies born to mothers with antiphospholipid syndrome
    2013
  36. Rožič Marjanca; Trampuš-Bakija Alenka; Rener-Primec Zvonka; Kitanovski Lidija; Kveder Tanja; Avčin Tadej
    Spectrum of thrombotic and non-thrombotic manifestations in 159 children with positive antiphospholipid antibodies
    2013
  37. Rotar Žiga; Rozman Blaž; De Groot P.G.; Sanmarco M; Shoenfeld Yehuda; Meroni PierLuigi; Cervera Ricard; Pengo V.; Cimaz Rolando; Avčin Tadej
    Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome?
    2009
  38. Ambrožič Aleš; Žigon Polona
    Detection and clinical significance of antiprothrombin antibodies
    2011
  39. APLA & LACA 2013
    2013
  40. Espinosa Gerard; Rodríguez-Pintó Ignasi; Gomez-Puerta José A; Praprotnik Sonja
    Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses
    2013
  41. [Final program and lectures]
    2013
  42. Žigon P; Čučnik S; Ambrožič A; Sodin-Šemrl S; Kveder T; Božič B
    Antibodies to phosphatidylserin/prothrombin complex as an additional diagnostic marker of APS? (PA15)
    2011
  43. Čučnik S; Kveder T; Artenjak A; Avčin T; Rozman B; Božič B
    3rd report on APL forum project avidity of anti-beta2-glycoprotein I antibodies in patients with antiphospholipid syndrome (2005-2011) (OFP05)
    2011
  44. Avčin T; Cimaz R; Silverman ED; Rozman B
    Long-term follow-up in children with APS: data from the international pediatric APS registry (OPF04)
    2011
  45. Anonymous ;
    Abstract book of the 8th Meeting of the European forum on antiphospholipid antibodies; 2011 Sep 29 - Oct 1; Padua
    2011
  46. Artenjak Andrej; Lakota Katja; Frank Mojca; Čučnik Saša; Rozman Blaž; Božič Borut; Shoenfeld Yehuda; Sodin-Šemrl Snežna
    Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review
    2012
  47. Janša Rado; Čučnik Saša; Ambrožič Aleš; Rozman Blaž; Kralj-Iglič Veronika
    Impact of antiphospholipid antibodies on mediated interaction between membranes - a microvesiculation-suppression effect
    2012
  48. De Laat B; Derksen RHWM; Reber G; Musial J; Swadzba J; Božič B; Čučnik S; Regnault V; Forastiero R; Woodhams BJ
    An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies
    2011
  49. Čučnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avčin T; Rozman B; Božič B
    Avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies
    2011
  50. Žigon Polona; Ambrožič Aleš; Čučnik Saša; Kveder Tanja; Rozman Blaž; Božič Borut
    Modified phosphatidylserine-dependent antiprothrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies
    2011
  51. Zager U; Lunder M; Čučnik S; Štrukelj B; Kveder T; Rozman B; Božič B
    Binding cgaracteristics of anti-beta2GPI paratopes revealed by phage display
    2010
  52. Žigon P; Ambrožič A; Čučnik S; Božič B; Kveder T; Rozman B
    Only aPS/PT ELISA detects low avidity antiprothrombin antibodies
    2010
  53. Hughes Graham RV; Pierangeli Silvia S; Bertolaccini Maria Laura; Khamashta Munther A
    Antiphospholipid by the Beach. Abstracts of the 13th International Congress on Antiphospholipid Antibodies; 2010 Apr 13-16; Galveston, Texas
    2010
  54. Omersel J; Čučnik S; Avberšek-Lužnik I; Kveder T; Rozman B; Božič B
    Oxidation of antibodies as a trigger for autoimmunity
    2010
  55. Omersel J; Jurgec I; Čučnik S; Kveder T; Rozman B; Sodin-Šemrl S; Božič B
    Autoimmune and proinflammatory activity of oxidized antibodies
    2007
  56. Kovačič J; Anderluh G; Božič B; Čučnik S; Derganc J; Majhenc J; Svetina S; Irman Š; Škarabot M; Muševič I
    In vitro models of aPL phospholipid membrane interactions-our experiences
    2010
  57. Božič Borut; Čučnik Saša; Gašperšič Nataša; Ambrožič Aleš; Kveder Tanja; Rozman Blaž
    Rational laboratory diagnostics of antiphospholipid antibodies: anticardiolipin, anti-beta2-glycoprotein I, anti-prothrombin and anti-annexin V antibodies
    2009
  58. Avčin T; Benseler SM; Tyrell PN; Čučnik S; Silverman ED
    A follow-up study of aPL and associated neuropsychiatric manifestations in 137 children with SLE
    2007
  59. Čučnik Saša; Kveder Tanja; Rozman Blaž; Božič Borut
    Avidity of anti-beta2 GPI antibodies in patients with antihospholipid syndrome
    2007
  60. Anonymous ;
    Program of the 6th meeting of the European forum on antiphospholipid antibodies; 2007 Oct 12-13; Ljubljana
    2007
  61. Irman Špela; Škarabot Miha; Rozman Blaž; Muševič Igor; Božič Borut
    Antiphospholipid antibodies and crystallization of annexin A5 on natural phospholipid supports
    2010
  62. Holc Iztok; Hojs Radovan; Čikeš Nada; Ambrožič Aleš; Čučnik Saša; Kveder Tanja; Rozman Blaž; Pahor Artur
    Atherosclerosis and antiphospholipid antibodies: insights from rheumatoid arthritis - a five year follow up study
    2010
  63. Blank M; Buccarelli S; Cervera R; Espinosa G; Altman A; Praprotnik S; Shoenfeld Y
    Histidine-rich-glycoprotein: a protective molecule in anti-beta2GPI mediated endothelial cell induced procoagulation state
    2010
  64. Praprotnik S; Agmon-Levin N; Potaz-Katz B; Blank M; Rozman B; Meroni P; Cervera R; Miesbach W; Scyper-Kravitz M; Stojanovich L
    Prolactin: does it have a role in the pathogenesis of antiphospholipid syndrome?
    2010
  65. Cervera R; Bucciarelli Silvia; Praprotnik Sonja; Šipek-Dolničar Alenka
    Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'
    2010
  66. Šuput Daša; Ambrožič Aleš; Stevanović Živojin; Tomšič Matija
    Successful valve replacement and uneventful follow-up in patients with antiphospholipid antibodies
    2009
  67. Boffa MC; Lachassine E; Boinot C; De Carolis S; Rovere-Querini P; Avčin T; Biasini-Rebaioli C; Le Toumelin P; Aurousseau MH; Tincani A
    European registry of babies born to mothers with antiphospholipid syndrome: a result update
    2009
  68. Avčin T; Cimaz R; Rozman B
    The Ped-APS Registry: the antiphospholipid syndrome in childhood
    2009
  69. Avčin Tadej; Cimaz Ronaldo; Silverman Earl D; Cervera Ricard; Gattorno Marco; Garay Sstella; Berkun Yackov; Sztajnbok Flavio R; Silva Clovis A; Rozman Blaž
    Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry
    2008
  70. Pahor Artur; Holc Iztok; Gradišnik Suzana
    Ateroskleroza in antifosfolipidna protitelesa pri bolnikih z revmatoidnim artritisom
    [Atherosclerosis and antiphospholipid antibodies in patients with rheumatoid arthritis]
    2008
  71. Avčin Tadej
    Antiphospholipid syndrome in children
    2008
  72. Meglič A; Grosek Š; Benedik-Dolničar M; Avčin T
    Atypical haemolytic uremic syndrome complicated by microangiopathic antiphospholipid-associated syndrome
    2008
  73. Avčin T; Benseler SM; Tyrell PN; Čučnik S; Silverman ED
    Longitudinal follow-up study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus
    2007
  74. Čučnik S; Kveder T; Rozman B; Božič B
    Differences in antigen binding of high and low avidity anti beta-glycoprotein I antibodies
    2007
  75. Božič B; Čučnik S; Kveder T; Rozman B
    Changes in specificity of common IgG during electrooxidation
    2007
  76. Avčin T; Benseler SM; Tyrrell PN; Čučnik S; Silverman ED
    A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus
    2008
  77. Lokar M; Frank M; Čučnik S; Urbanija J; Iglič A; Kralj-Iglič V; Rozman B
    Antagonist effect of antiphospholipid antibodies and beta-2 glycoprotein I on budding phospholipid vesicles
    2007
  78. Avčin Tadej; Toplak Nataša
    Antiphospholipid antibodies in response to infection
    2007
  79. Avčin T; Silverman ED
    Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome
    2007
  80. Štalc Monika
    Ocenjevanje endotelijske funkcije pri bolnikih z antifosfolipidnim sindromom
    2007
  81. Tomšič Nejc
    Vpliv kardiolipina in holesterola na lastnosti fosfolipidnih mehurčkov in njihove interakcije z okolno raztopino
    2006
  82. Salobir Barbara; Šabovič Mišo; Hojnik Maja; Čučnik Saša; Kveder Tanja
    Anti-beta2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease
    2007
  83. Ambrožič Aleš; Čučnik Saša; Tomšič Nejc; Urbanija Jasna; Lokar Maruša; Babnik Blaž; Rozman Blaž; Iglič Aleš; Kralj-Iglič Veronika
    Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies
    2006
  84. Gašperšič N; Ambrožič A; Božič B; Majhenc J; Svetina S; Rozman B
    Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies
    2007
  85. Pahor Artur
    Pojavnost zgodnjih znakov ateroskleroze in pomen vnetnih dejavnikov za razvoj ateroskleroze pri bolnicah z revmatoidnim artritisom
    [The prevalance of early signs of atherosclerosis and the role of inflammatory factors for atherosclerosis in female rheumatoid arthritis patients]
    2006
  86. Ambrožič Aleš; Tomšič Matija
    Antifosfolipidni sindrom - nova diagnostična merila in prikaz primera
    [Antiphospholipid syndrome - new classification criteria and case report]
    2006
  87. Pahor Artur; Hojs Radovan; Holc Iztok; Ambrožič Aleš; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis
    2006
  88. Lukač Janja; Čučnik Saša; Kveder Tanja; Strle Franc; Rozman Blaž
    Anti-beta2-glycoprotein I antibodies in Lyme borreliosis: differences in disease stage and immunoglobulin class distribution
    2006
  89. Sodin-Šemrl S; Žigon P; Čučnik S; Kveder T; Blinc A; Tomšič M; Rozman B
    Serum amyloid A in autoimmune thrombosis
    2006
  90. Avčin Tadej; Benseler Susanne M; Tyrrell Pascal N; Silverman Earl D
    Longitudinal follow-up study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus
    2005
  91. Boffa Marie Claire; Lachassinne E; Schlegel N; Aurousseau MH; Avčin T; Rai R; Farge-Bancel D; Piette JC; Uzan M; Regan L
    Fetal or perinatal thrombosis in infants born to mothers having antiphospholipid antibodies. Opening of a register
    2006
  92. Boffa M-C; Aurousseau M-H; Lachassinne E; Dauphin H; Fain O; Le-Toumelin P; Uzan M; Piette J-C; Derenne S; Boinot C; Avčin T; Motta M; Faden D; Tincani A
    European register of babies born to mothers with antiphospholipid syndrome
    2004
  93. Urbanija Jasna; Lokar Maruša; Ambrožič Aleš; Čučnik Saša; Rozman Blaž; Iglič Aleš; Kralj-Iglič Veronika
    Differences in the effect of antiphospholipid antibodies and beta2-glycoprotein-1 on the morphology of giant phospholipid vesicles
    2006
  94. Martinuč-Porobič J; Avčin T; Božič B; Kuhar M; Čučnik S; Zupančič M; Prosenc K; Kveder T; Rozman B
    Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine
    2005
  95. Avčin Tadej; Cimaz Rolando; Cervera Ricard; Ravelli Angelo; Martini Alberto; Rozman Blaž; Meroni PierLuigi
    Register for pediatric patients with antiphospholipid syndrome (European project extended internationally)
    2005
  96. Božič Borut; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Avidity of anti-beta2-glycoprotein 1 antibodies in patients with antiphospholipid syndrome
    2005
  97. Anonymous ;
    5th meeting of the European forum on antiphospholipid antibodies; 2005 Dec 2-3; Barcelona
    2005
  98. Božič Borut; Irman Špela; Gašperšič Nataša; Kveder Tanja; Rozman Blaž
    Antibodies against annexin A5: detection pitfalls and clinical associations
    2005
  99. Čučnik S; Božič B; Kveder T; Tomšič M; Rozman B
    Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome
    2005
  100. Asherson RA; Espinosa G; Cervera R; Gomez-Puerta JA; Musuruana J; Bucciarelli S; Ramos-Casals M; Martinez-Gonzalez AL; Praprotnik S; Šipek-Dolničar A
    Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients
    2005

1 101  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics